Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00188539 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment target: estimated 300 to confirmed 346v17
  2. Primary and study completion dates: Dec 2024 to Dec 2027v16
  3. Primary and study completion dates: Dec 2023 to Dec 2024v15
  4. Re-verified, no change to tracked fieldsv14
  5. Primary and study completion dates: Dec 2022 to Dec 2023v13
Show 11 earlier versionsHide 11 earlier versions
  1. Primary and study completion dates: Dec 2021 to Dec 2022v12
  2. Re-verified, no change to tracked fieldsv11
  3. Primary and study completion dates: Dec 2020 to Dec 2021v10
  4. Re-verified, no change to tracked fieldsv9
  5. Primary and study completion dates: Dec 2019 to Dec 2020v8
  6. Primary completion date: Dec 2017 to Dec 2019 Completion date: Dec 2018 to Dec 2019v7 Show all 2 changesShow less
    • Completion date: Dec 2018 to Dec 2019
  7. Primary completion date: Dec 2016 to Dec 2017 Completion date: Dec 2016 to Dec 2018v6 Show all 2 changesShow less
    • Completion date: Dec 2016 to Dec 2018
  8. Collaborators revised (2)v5 Show moreShow less

    See this version in full on ClinicalTrials.gov ↗

  9. Primary and study completion dates: Dec 2014 to Dec 2016v4
  10. Primary and study completion dates: Dec 2013 to Dec 2014v3
  11. Trial status: Recruiting to Active, Not Recruiting Primary and study completion dates: Dec 2013 · Secondary endpoints: details revised at 1 of 1 entry · Site details revised · 2 morev2 Show all 6 changesShow less
    • Primary and study completion dates: Dec 2013
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
    • Collaborators revised (2)
    • Study arms: 0 to 1

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to measure the oxygen content and interstitial fluid pressure in cervix cancer patients. Tumour oxygen content and internal pressure of tumours may be an important factor that influences the effectiveness of radiotherapy and other treatments.
Trial Details
NCT Number NCT00188539
Lead Sponsor University Health Network, Toronto
Collaborators: Canadian Cancer Trials Group, Princess Margaret Hospital, Canada
Conditions Cervix Neoplasms
Enrollment 346 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov